Balkis Meddeb

Eltrombopag for the Treatment of Chronic Idiopathic Thrombocytopenic Purpura

James B. Bussel, Gregory Cheng, Mansoor N. Saleh et al. · New England Journal of Medicine · 2007 · 805 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Frontline bortezomib, rituximab, cyclophosphamide, doxorubicin, and prednisone (VR-CAP) versus rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in transplantation-ineligible patients with newly diagnosed mantle cell lymphoma: final overall survival results of a randomised, open-label, phase 3 study

Tadeusz Robak, Jie Jin, Halyna Pylypenko et al. · The Lancet Oncology · 2018 · 140 citations

Medicine, Hematology, Oncology +15

Rituximab plus bendamustine or chlorambucil for chronic lymphocytic leukemia: primary analysis of the randomized, open-label MABLE study

Anne‐Sophie Michallet, Melih Aktan, Wolfgang Hiddemann et al. · Haematologica · 2018 · 76 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Factors associated with severe sepsis: prospective study of 94 neutropenic febrile episodes

Ramzi Jeddi, M. Achour, R. Ben Amor et al. · Hematology · 2010 · 45 citations · Full text

Veterinary Medicine, Hematology, Infectious Diseases +17

Predictive factors of septic shock and mortality in neutropenic patients

Ramzi Jeddi, Mohamed Zarrouk, Benabdennebi Yosr et al. · Hematology · 2007 · 41 citations

Life Sciences, Infectious Diseases, Microbiology +16